Send feedback

RNF43 p.Pro686Arg

c.2057C>G · rs9652855 · VCV1169209

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 9 submitters
AlphaMissense
likely benign
0.0837 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 15.3%, mid) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense0.0837likely benign
REVEL0.044moderately benign-leaning
SaProtLLR -7.81tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.7GERP -0.26, phastCons 1
Regional constrainto/e 0.77unconstrained · MANE · 61 kb · p 1.7e-13 · regional, not allelic
Overall
CADD7.655PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 15.3% Middle Eastern · 922/6,044 alleles
Filtering AF 14.4% ClinGen BA1/BS1 input FAF95, joint · FAF99 14.1%
Overall 11.4% 183,759/1,611,466 alleles · common exomes 166,749/1,459,162 · genomes 17,010/152,304 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 17.2% 6
Middle Easterngrpmax 15.3% 7
European (non-Finnish) 12.4% 8
African / African-American 12% 8
Remaining individualsnot grpmax-eligible 11.6% 9
Finnishnot grpmax-eligible 9.7% 10
Admixed American 7.16% 14
Amishnot grpmax-eligible 6.36% 16
South Asian 5.94% 17
East Asian 0.0201% 4,986

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
RNF43
Protein
p.Pro686Arg
Coding
c.2057C>G
MANE Select
NM_017763
dbSNP
rs9652855
Type
single nucleotide variant
Location
chr17:58357719 (GRCh38)
Gene constraint
LOEUF 0.632 · pLI <0.01 · ClinGen HI 2/3 (gnomAD)
Structure
AlphaFold pLDDT 55.86 · 2 PDB
Residue 686
a UniProt-annotated variant site (in)
Full RNF43 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rnf43-p-pro686arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown